Longitudinal Advanced Prostate Cancer Cohort (LAPCC)

Recruiting

• Conditions: Prostate Carcinoma
• Interventions: Other: Non-Interventional Study

• Registration Number: NCT06067295
• Lead Sponsor: University of Southern California

Brief Summary

This study examines information from patients with prostate cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). By collecting biological samples (like blood, urine, and tissue), and health information (such as treatment, diet, and quality of life) researchers hope to learn more about prostate cancer and ways to improve outcomes in the future.

Detailed Description

PRIMARY OBJECTIVE:

I. To create an annotated biorepository with prospectively collected blood and urine samples from men with advanced prostate cancer.

OUTLINE: This is an observational study.

Patients undergo blood and urine sample collection, complete surveys, and have their medical records reviewed on study.

Study Timeline

• Study Start: 2023-02-21
• Study First Submitted: 2023-09-27
• Study First Submitted QC: 2023-09-27
• Study First Posted: 2023-10-04
• Status Verified: 2024-10
• Last Update Submitted: 2024-10-08
• Last Update Posted: 2024-10-10
• Primary Completion: 2026-02-21
• Study Completion: 2027-02-21

Recruitment & Eligibility

• Status: RECRUITING
• Sex: Male
• Target Recruitment: 150

Inclusion Criteria

• * Men of all racial and ethnic groups 18 years of age or older

  • Men with a diagnosis of advanced (metastatic) prostate cancer who are scheduled to begin a new systemic treatment (including first or subsequent lines of therapy)
  • Prior participation on clinical trials is allowed

Exclusion Criteria

• * Inability to give informed consent

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Observational	Non-Interventional Study	Patients undergo blood and urine sample collection, complete surveys, and have their medical records reviewed on study.

Primary Outcome Measures

Name	Time	Method
Collection of biological specimens and clinical data for future research related to prostate cancer.	Up to 5 years	The objective of this study is to create a biorepository of biospecimen and clinical data. There is no primary clinical outcome for this study.

Trial Locations

Locations (2)

Los Angeles County-USC Medical Center; 🇺🇸 Los Angeles, California, United States

USC / Norris Comprehensive Cancer Center; 🇺🇸 Los Angeles, California, United States